4
total announcements
CORONA.NS · 15 min delayed
CORONA Remedies Limited
CORONA Remedies Limited has informed the Exchange about the schedule of its Q1 FY27 earnings conference call to discuss the financial results for the first quarter and three months ended June 30, 2026.
CORONA Remedies Limited
CORONA Remedies Limited has submitted the Exchange a copy Scrutinizer report of Annual General Meeting held on July 09, 2026, and informed the Exchange regarding voting results.
CORONA Remedies Limited
CORONA Remedies Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on July 09, 2026, where the company passed various resolutions including final dividend declaration, auditor appointment, and director re-appointment.
CORONA Remedies Limited
CORONA Remedies Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the first quarter ended June 30, 2026.